Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.

Blood - 4 May 2017

Lal Ridhima, Lind Karin, Heitzer Ellen, Ulz Peter, Aubell Kristina, Kashofer Karl, Middeke Jan M, Thiede Christian, Schulz Eduard, Rosenberger Angelika, Hofer Sybille, Feilhauer Birgit, Rinner Beate, Svendova Vendula, Schimek Michael G, Rücker Frank G, Hoefler Gerald, Döhner Konstanze, Zebisch Armin, Wölfler Albert, Sill Heinz

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Cancer Genomics and Diagnostics
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Sarcoma Diagnosis and Treatment

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 28258055
DOI: 10.1182/blood-2016-11-751008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.PMID 28258055Read ↗

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.Semantic proximity Read ↗

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?Semantic proximity Read ↗

Clinical implications of subclonal TP53 mutations in acute myeloid leukemiaSemantic proximity Read ↗

Acute Myeloid Leukemia and Myelodysplastic Syndromes with TP53 Aberrations - A Distinct Stem Cell Disorder.Semantic proximity Read ↗

Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.Semantic proximity Read ↗

Recent advances in the understanding of TP53 in haematological malignancies.Semantic proximity Read ↗

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.Semantic proximity Read ↗

What have we learned about TP53-mutated acute myeloid leukemia?Semantic proximity Read ↗

TP53 mutations in therapy-related acute myeloid leukemia: still the dark side of the moon?Semantic proximity Read ↗

TP53 in AML and MDS: The new (old) kid on the block.Semantic proximity Read ↗

TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation.Semantic proximity Read ↗

Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.